Steri-Strip Tape Use in Unilateral Ectropion Surgery
Postoperative Outcomes of Steri-Strip Surgical Tape Use in Unilateral Ectropion Surgery: A Parallel-Controlled Clinical Trial
1 other identifier
interventional
74
1 country
1
Brief Summary
Currently, the incidence of involutional and chronic eyelid disorders, such as ectropion, has been increasing, as human life expectancy has risen worldwide (more than 600 million people are aged ≥ 60 years). Ectropion is a common eyelid malposition that causes visual morbidity. It is characterized by eversion of the eyelid margin and has multiple etiologies. Steri-Strip tapes have been used in some ophthalmologic procedures, such as blepharoplasties, where they help prevent infections by acting as a barrier method, are resistant enough to reduce the risk of wound dehiscence, simplify postoperative care, and allow for proper eyelid fissure closure. Their use has been recommended in patients with facial paralysis to prevent keratitis or exposure ulcers. However, current evidence is limited, as their use has only been documented in case series and letters to the editor. Therefore, a randomized controlled clinical trial is proposed to evaluate the postoperative outcomes of Steri-Strip tape use in unilateral ectropion surgery compared to standard postoperative management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2025
CompletedFirst Posted
Study publicly available on registry
April 20, 2025
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedJune 11, 2025
June 1, 2025
9 months
April 11, 2025
June 6, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Eyelid position
This outcome will be assessed using the margin reflex distance 2 (MRD2), which will be measured in millimeters (mm) from the central corneal light reflex (Hirschberg reflex) to the center of the lower eyelid margin. If this measurement exceeds 5 mm, it suggests that the tapes did not provide adequate support.
Measurements will be taken in the immediate postoperative period (within the first hour) and at 30 days following surgery.
Secondary Outcomes (3)
Surgical wound closure
This will be assessed on postoperative day 8
Visual axis obstruction secondary to peripalpebral edema
It will be assessed on postoperative day 8.
Ocular surface symptoms
This outcome will be assessed on postoperative days 8 and 30.
Study Arms (2)
Use Steri-Strip in post-surgery + standard care
ACTIVE COMPARATORWithin the first hour after unilateral ectropion surgery, Steri-Strip tapes (6 mm wide × 100 mm long, pack of 10 strips) will be applied to the operated eye. Six of these strips will be placed obliquely, hammock-style, 3 mm below the inferior orbital rim to direct the tension forces upward, using the lateral canthus of the operated eye as support. An additional strip will be placed horizontally, 2 mm above the orbital rim. The Steri-Strip tapes will be removed 8 days after surgery.
Standard care
OTHERStandard care for ectropion surgery refers to the usual postoperative management provided without the use of additional supportive devices such as Steri-Strip tapes. It typically includes the application of ophthalmic antibiotic ointment, cold compresses, and instructions for eyelid hygiene.
Interventions
Steri-strip will be maintained for 8 days postoperatively.
Eligibility Criteria
You may qualify if:
- Patients aged 18 years or older who are scheduled to undergo unilateral ectropion surgery.
You may not qualify if:
- Underlying conditions associated with skin hyperlaxity, such as cutis laxa and Ehlers-Danlos syndrome.
- Skin diseases that predispose to cicatricial ectropion, such as ichthyosis, scleroderma, and psoriasis.
- Paralytic ectropion.
- Current use of oral isotretinoin.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oftalmosanitas
Bogotá, Colombia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tatiana Gomez, MD
Unisanitas
Central Study Contacts
Johana Benavides, MSc
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
April 11, 2025
First Posted
April 20, 2025
Study Start
May 1, 2025
Primary Completion
February 1, 2026
Study Completion
February 1, 2026
Last Updated
June 11, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share